BMJ · 2020 · 67 citations · 18 references
PharmacyPharmaceutical PolicyRegulatory PharmacyDrug Approval ProcessesPharmaceutical RegulationAccess To MedicinesBiosimilar RegulationMedication AccessPharmaceutical EconomicsPharmaceutical MarketingPharmacoeconomic EvaluationAccess To BiosimilarsBiosimilar FinancingBiosimilar MarketingGeneric Drug MarketingGeneric Drug PricingGeneric Medicine Market CompetitionMarket Access For BiosimilarsMedicines Pricing Policy
Early market entry and rapid uptake of quality assured generic and biosimilars are key to improving access to medicines, say Alessandra Ferrario and colleagues
18
Policies for biosimilar uptake in Europe: An overview
Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text
Erwin A. Blackstone, P Fuhr Joseph · PubMed · 2013 · 177 citations